Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

0.435
Delayed Data
As of Oct 19
 -0.0321 / -6.87%
Today’s Change
0.26
Today|||52-Week Range
2.15
-67.05%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close0.47
Today’s open0.46
Day’s range0.43 - 0.48
Volume768,136
Average volume (3 months)1,109,153
Market cap$17.6M
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)-52.86%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.98

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...+0.00+0.67%
HEBHemispherx Biopharma...+0.01+3.77%
ITUSITUS Corp-0.08-3.01%
SBOTStellar Biotechnolog...-0.07-5.42%
Data as of 6:29pm ET, 10/19/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$17.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Larry M. Dillaha
CFO, Secretary &
Principal Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts